Asia Pacific Human Papillomavirus (HPV) Vaccine Market Forecast to 2028

Report Code : BMIRE00026298 | Region : Asia Pacific | Industry : Pharmaceuticals | Published Date : 26/Sep/2022
Asia Pacific Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others)

The APAC human papillomavirus (HPV) vaccine market is expected to grow from US$ 567.57 million in 2022 to US$ 826.34 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2022 to 2028.

Companies are undertaking many research and development activities to introduce advanced HPV tests. For instance, in May 2021, BD, a leading medical technology company, launched the first CE-marked assay for HPV screening from at-home self-collected vaginal samples. This allows laboratories to process self-collected samples via a BD diluent tube. At-home collection of samples will help address the urgent public health challenge of reaching out to women who do not attend routine cervical cancer screening. Further, in September 2020, drug administrations across the region approved the expanded use of F. Hoffmann-La Roche Ltd, CINtec PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). The CINtec PLUS Cytology test identifies the simultaneous presence of the two biomarkers -- p16 and Ki-67 in a single cell. This abnormality is associated with HPV infections that progress to pre-cancer or cancer if not treated. A positive result of these two biomarkers is more significantly at risk for disease. Such robust developments in HPV diagnostics tests are likely to reshape the HPV vaccines market during the forecast period.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC human papillomavirus (HPV) vaccine market . The APAC human papillomavirus (HPV) vaccine market is expected to grow at a good CAGR during the forecast period.

APAC Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

APAC Human Papillomavirus (HPV) Vaccine Market Segmentation

The APAC human papillomavirus (HPV) vaccine market is segmented based on type, dosage, age, application, end user, and country. Based on type, the APAC human papillomavirus (HPV) vaccine market is segmented into 9-valent HPV vaccine, quadrivalent HPV vaccine, and bivalent HPV vaccine. The quadrivalent HPV vaccine segment dominated the market in 2022. Based on dosage, the APAC human papillomavirus (HPV) vaccine market is bifurcated into 2 dose and 3 dose. The 2 dose segment dominated the market in 2022. Based on age, the APAC human papillomavirus (HPV) vaccine market is bifurcated into 9 to 14 years and 15 to 45 years. The 9 to 14 years segment dominated the market in 2022. Based on application, the APAC human papillomavirus (HPV) vaccine market is bifurcated into HPV-attributable cancer and genital warts. The HPV-attributable cancer segment dominated the market in 2022. Based on end user, the APAC human papillomavirus (HPV) vaccine market is segmented into doctors office, community health clinics, school-based health centers, health departments, hospitals, and others. The hospitals segment dominated the market in 2022. Based on country, the APAC human papillomavirus (HPV) vaccine market has been categorized into China, Japan, India, Australia, Southeast Asia, New Zealand, South Korea, and the Rest of APAC. China would dominate the market in 2022.

ChengDu Institute of Biological Products Co., Ltd.; GlaxoSmithKline plc.; Inovio Pharmaceuticals; Merck & Co., Inc.; R-Pharm; Sanofi; Serum Institute of India Pvt. Ltd; Vaccitech; Walvax Biotechnology Co., Ltd.; and Xiamen Innovax Biotech CO., LTD. are among the leading companies in the APAC human papillomavirus (HPV) vaccine market.

The List of Companies - Asia Pacific Human Papillomavirus (HPV) Vaccine Market

● ChengDu Institute of Biological Products Co., Ltd.

● GlaxoSmithKline plc.

● Inovio Pharmaceuticals

● Merck & Co., Inc.

● R-Pharm

● Sanofi

● Serum Institute of India Pvt. Ltd

● Vaccitech  

● Walvax Biotechnology Co., Ltd.

● Xiamen Innovax Biotech CO., LTD.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Human Papillomavirus (HPV) Vaccines Market – By Type

1.3.2 APAC Human Papillomavirus (HPV) Vaccines Market – By Dosage

1.3.3 APAC Human Papillomavirus (HPV) Vaccines Market – By Age

1.3.4 APAC Human Papillomavirus (HPV) Vaccines Market – By Application

1.3.5 APAC Human Papillomavirus (HPV) Vaccines Market – By Distribution Channel

1.3.6 APAC Human Papillomavirus (HPV) Vaccines Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Human Papillomavirus (HPV) Vaccine Market – Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Human Papillomavirus (HPV) Vaccine Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of HPV Associated Diseases

5.1.2 Initiatives Taken by Health Organizations

5.2 Market Restraints

5.2.1 High Cost of HPV Vaccines

5.3 Market Opportunities

5.3.1 Growing Number of HPV Awareness Programs

5.4 Future Trends

5.4.1 Advancements in HPV Diagnostics Tests

5.5 Impact Analysis

6. Human Papillomavirus (HPV) Vaccine Market– APAC Analysis

6.1 APAC Human Papillomavirus (HPV) Vaccine Market Revenue Forecast and Analysis

7. APAC Human Papillomavirus (HPV) Vaccine Market Analysis – By Type

7.1 Overview

7.2 By Type: Market Revenue and Forecast Analysis (US$ Million)

7.3 9-valent HPV vaccine

7.3.1 Overview

7.3.2 9-valent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)

7.4 Quadrivalent HPV vaccine

7.4.1 Overview

7.4.2 Quadrivalent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)

7.5 Bivalent HPV Vaccine

7.5.1 Overview

7.5.2 Bivalent HPV Vaccine Market Revenue and Forecast to 2028 (US$ Million)

8. APAC Human Papillomavirus (HPV) Vaccine Market Analysis - By Dosage

8.1 APAC Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Dosage (2022 and 2028)

8.2 2 Dose

8.2.1 Overview

8.2.2 2 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

8.3 3 Dose

8.3.1 Overview

8.3.2 3 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

9. APAC Human Papillomavirus (HPV) Vaccine Market Analysis - By Age

9.1 APAC Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Age (2022 and 2028)

9.2 9 to 14 Years

9.2.1 Overview

9.2.2 9 to 14 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

9.3 to 45 Years

9.3.1 Overview

9.3.2 to 45 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

10. APAC Human Papillomavirus (HPV) Vaccine Market Analysis - By Application

10.1 APAC Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Application (2022 and 2028)

10.2 HPV-attributable Cancer

10.2.1 Overview

10.2.2 HPV-attributable Cancer: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

10.3 Genital Warts

10.3.1 Overview

10.3.2 Genital Warts: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

11. APAC Human Papillomavirus (HPV) Vaccine Market Analysis – By End User

11.1 Overview

11.2 APAC Human Papillomavirus (HPV) Vaccine Market Revenue Share, by End User (2022 and 2028)

11.3 Doctor Office

11.3.1 Overview

11.3.2 Doctor Office Market Revenue and Forecast to 2028 (US$ Million)

11.4 Community Health Clinics

11.4.1 Overview

11.4.2 Community Health Clinics Market Revenue and Forecast to 2028 (US$ Million)

11.5 School-based Health Centers

11.5.1 Overview

11.5.2 School-based Health Centers Market Revenue and Forecast to 2028 (US$ Million)

11.6 Health Departments

11.6.1 Overview

11.6.2 Health Departments Market Revenue and Forecast to 2028 (US$ Million)

11.7 Hospitals

11.7.1 Overview

11.7.2 Hospitals Market Revenue and Forecast to 2028 (US$ Million)

11.8 Others

11.8.1 Overview

11.8.2 Others Market Revenue and Forecast to 2028 (US$ Million)

12. APAC Human Papillomavirus (HPV) Vaccine Market - Country Analysis

12.1 Overview

12.1.1 APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Country (2022 & 2028)

12.1.1.1 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.1.1 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.1.2 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.1.1.1.3 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.1.1.1.4 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.1.1.1.5 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.1.1.1.6 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.1.1.2 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.2.1 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.2.2 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.1.1.2.3 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.1.1.2.4 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.1.1.2.5 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.1.1.2.6 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.1.1.3 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.3.1 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.3.2 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.1.1.3.3 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.1.1.3.4 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.1.1.3.5 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.1.1.3.6 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.1.1.4 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.4.1 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.4.2 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.1.1.4.3 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.1.1.4.4 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.1.1.4.5 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.1.1.4.6 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.1.1.5 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.5.1 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.5.2 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.1.1.5.3 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.1.1.5.4 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.1.1.5.5 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.1.1.5.6 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.1.1.6 New Zealand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.6.1 New Zealand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.6.2 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.1.1.6.3 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.1.1.6.4 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.1.1.6.5 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.1.1.6.6 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.1.1.7 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.7.1 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.7.2 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.1.1.7.3 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.1.1.7.4 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.1.1.7.5 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.1.1.7.6 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.1.1.8 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.8.1 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.8.2 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.1.1.8.3 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.1.1.8.4 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.1.1.8.5 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.1.1.8.6 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.1.1.9 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.9.1 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.9.2 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.1.1.9.3 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.1.1.9.4 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.1.1.9.5 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.1.1.9.6 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.1.1.10 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.10.1 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.10.2 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.1.1.10.3 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.1.1.10.4 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.1.1.10.5 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.1.1.10.6 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.1.1.11 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.11.1 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.11.2 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.1.1.11.3 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.1.1.11.4 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.1.1.11.5 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.1.1.11.6 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.1.1.12 Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.1.1.12.1 Rest of APAC: Human Papillomavirus (HPV) Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

12.1.1.12.2 Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.1.1.12.3 Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.1.1.12.4 Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.1.1.12.5 Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.1.1.12.6 Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

13. Industry Landscape

13.1 Overview

13.2 Inorganic Growth Strategies

13.2.1 Overview

13.3 Organic Growth Strategies

13.3.1 Overview

14. Company Profiles

14.1 Merck & Co., Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 GlaxoSmithKline plc.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 INNOVAX Xiamen Innovax Biotech CO., LTD.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Serum Institute of India Pvt. Ltd

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Walvax Biotechnology Co., Ltd.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Inovio Pharmaceuticals

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Vaccitech

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 ChengDu Institute of Biological Products Co., Ltd.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Sanofi

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 R-Pharm

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES.

Table 1.             APAC Human Papillomavirus (HPV) Vaccine Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 3.             Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 4.             Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 5.             Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 6.             Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 7.             China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 8.             China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 9.             China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 10.          China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 11.          China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 12.          India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 13.          India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 14.          India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 15.          India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 16.          India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 17.          South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 18.          South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 19.          South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 20.          South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 21.          South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 22.          Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 23.          Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 24.          Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 25.          Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 26.          Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 27.          New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 28.          New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 29.          New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 30.          New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 31.          New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 32.          Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 33.          Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 34.          Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 35.          Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 36.          Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 37.          Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 38.          Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 39.          Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 40.          Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 41.          Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 42.          Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 43.          Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 44.          Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 45.          Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 46.          Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 47.          Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 48.          Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 49.          Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 50.          Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 51.          Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 52.          Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 53.          Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 54.          Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 55.          Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 56.          Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 57.          Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 58.          Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 59.          Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 60.          Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 61.          Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 62.          Recent Inorganic Growth Strategies

Table 63.          Recent Organic Growth Strategies

Table 64.          Glossary of Terms

The List of Companies - Asia Pacific Human Papillomavirus (HPV) Vaccine Market

● ChengDu Institute of Biological Products Co., Ltd.

● GlaxoSmithKline plc.

● Inovio Pharmaceuticals

● Merck & Co., Inc.

● R-Pharm

● Sanofi

● Serum Institute of India Pvt. Ltd

● Vaccitech  

● Walvax Biotechnology Co., Ltd.

● Xiamen Innovax Biotech CO., LTD.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC human papillomavirus (HPV) vaccine market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the APAC human papillomavirus (HPV) vaccine market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the human papillomavirus (HPV) vaccine market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Asia Pacific Human Papillomavirus (HPV) Vaccine Market Forecast to 2028)
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry